Funding

Consortium nabs $10M European grant to develop drug response tests for CKD
The Prime-CKD consortium is funded by Horizon Europe. Approximately $1 million of the total amount is targeted for commercial translation activities to be undertaken by Renalytix.
January 26, 2023
Kidney Social
Hologic awarded $19M by BARDA to develop COVID-19 assays to FDA IVD standards
Hologic announced that the funding will be used to bring its two COVID assays up to the FDA’s IVD standards.
November 2, 2022
Coronavirus Business Graphic
Day Zero awarded $8.2 million in CARB-X funding
Day Zero is developing diagnostic tests that use genome sequencing and machine-learning algorithms to rapidly identify pathogens and their antibacterial-resistance profiles.
October 20, 2022
Sepsis Bacteria Social
Diadem nabs $2.5M to further validate Alzheimer’s blood test
The two-year grant will enable Diadem, a company that has been developing a blood-based test for the early prediction of Alzheimer's disease (AD), to leverage data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a longitudinal multicenter study designed to enable development of biomarkers for the early detection and tracking of AD.
September 6, 2022
2022 09 07 17 41 6639 Nerve Neuron Axon 400
VolitionRx prices $6M public offering
The company said that gross proceeds to Volition from the offering are expected to be $6 million. Volition also granted the underwriter a 30-day option to purchase up to an additional 450,000 shares of its common stock at the public offering price. The offering is expected to close on or about August 2.
July 28, 2022
2019 04 26 21 48 5250 Money Hundred Bills 400
AACR announces 2022 cancer research award recipients
The award recognizes female researchers who have made pioneering contributions to the understanding and treatment of breast and gynecological cancer. This year's awardees include:
April 3, 2022
2019 09 20 23 44 6333 Trophy Award 400
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Foundation Medicine secures FDA 'breakthrough' designation
The FDA granted the designation for use of the assay in detecting molecular residual disease (MRD) in early-stage cancer after curative therapy. These test results can then help to guide further treatment decisions in these patients, according to the vendor.
February 14, 2022
2019 10 09 17 32 0093 Dna Cancer Cell 400
SLAS 2022: 6 tips for scientists looking to start companies
1. Find the right team
February 8, 2022
2022 02 09 00 27 2956 Business Lab Startup Team 400
Fla. university awarded $1.3M from NIH for HIV test
With the grant, FAU researchers hope to develop an affordable, disposable self-testing HIV-1 chip that can selectively detect HIV from whole blood samples. The researchers are aiming for an automated test that requires no refrigeration and can produce results within 40 minutes. They also said it will be sensitive enough to detect HIV during acute infection, treatment, and viral rebound, according to a press release issued by the university.
January 17, 2022
2019 06 24 22 49 6342 Lab Hiv Test 400
Siemens gets FDA nod for ELF test for liver fibrosis
ELF is a noninvasive blood test intended for use with the company's Advia Centaur XP immunoassay system. The test provides a numeric score that is automatically generated via an algorithm and is used to assess the likelihood of progressing to cirrhosis and liver-related clinical events in patients with severe or advanced fibrosis (F3 or F4) due to nonalcoholic steatohepatitis (NASH).
August 23, 2021
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Researchers get $3.3M to study AI in oral cancer
The U.S. National Cancer Institute awarded the five-year grant to a group led by Anant Madabhushi, PhD, the Donnell Institute Professor of Biomedical Engineering at CWRU and head of the Center for Computational Imaging and Personalized Diagnostics, and Dr. James Lewis Jr., a pathology, microbiology, and immunology professor at Vanderbilt University Medical Center.
January 5, 2021
2020 03 24 20 53 4672 Dollar Sign Golden 400
Liver cancer diagnostic test offers promise of early detection
The platform is called EV Click Chips, and the hope is that it will enable more effective purification of extracellular vesicles in blood from people with hepatocellular carcinoma. Researchers from the University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center have received a $2.97 million grant from the U.S. National Cancer Institute (NCI) to develop the technology further.
August 4, 2020
2020 01 22 00 12 9591 Liver Cancer 400
Page 1 of 3
Next Page